Revenue and EBITDA Negatively Impacted by Customer-Driven Project DelaysTremendous Q4 Bookings at Over $210 million Establishes New Record and Highest-Ever Backlog Completed Acquisition of Verantis ...
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, ...